372 related articles for article (PubMed ID: 20729465)
21. Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.
Aeinehband S; Brenner P; Ståhl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Brain Behav Immun; 2016 Jan; 51():47-55. PubMed ID: 26189678
[TBL] [Abstract][Full Text] [Related]
22. Acute liver failure increases kynurenic acid production in rat brain via changes in tryptophan metabolism in the periphery.
Sekine A; Fukuwatari T
Neurosci Lett; 2019 May; 701():14-19. PubMed ID: 30738081
[TBL] [Abstract][Full Text] [Related]
23. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
[TBL] [Abstract][Full Text] [Related]
24. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
[TBL] [Abstract][Full Text] [Related]
25. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
[TBL] [Abstract][Full Text] [Related]
26. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
[TBL] [Abstract][Full Text] [Related]
27. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
[TBL] [Abstract][Full Text] [Related]
28. The kynurenine pathway is involved in bacterial meningitis.
Coutinho LG; Christen S; Bellac CL; Fontes FL; Souza FR; Grandgirard D; Leib SL; Agnez-Lima LF
J Neuroinflammation; 2014 Oct; 11():169. PubMed ID: 25274277
[TBL] [Abstract][Full Text] [Related]
29. Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro.
Sekine A; Okamoto M; Kanatani Y; Sano M; Shibata K; Fukuwatari T
Springerplus; 2015; 4():48. PubMed ID: 25674503
[TBL] [Abstract][Full Text] [Related]
30. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
[TBL] [Abstract][Full Text] [Related]
31. The immune-kynurenine pathway in social anxiety disorder.
Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder.
Olsson SK; Sellgren C; Engberg G; Landén M; Erhardt S
Bipolar Disord; 2012 Nov; 14(7):719-26. PubMed ID: 23030601
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia.
Kindler J; Lim CK; Weickert CS; Boerrigter D; Galletly C; Liu D; Jacobs KR; Balzan R; Bruggemann J; O'Donnell M; Lenroot R; Guillemin GJ; Weickert TW
Mol Psychiatry; 2020 Nov; 25(11):2860-2872. PubMed ID: 30940904
[TBL] [Abstract][Full Text] [Related]
34. Kynurenine metabolism in Alzheimer's disease.
Baran H; Jellinger K; Deecke L
J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
[TBL] [Abstract][Full Text] [Related]
35. Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.
Holtze M; Saetre P; Engberg G; Schwieler L; Werge T; Andreassen OA; Hall H; Terenius L; Agartz I; Jönsson EG; Schalling M; Erhardt S
J Psychiatry Neurosci; 2012 Jan; 37(1):53-7. PubMed ID: 21693093
[TBL] [Abstract][Full Text] [Related]
36. Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.
Hare SM; Adhikari BM; Mo C; Chen S; Wijtenburg SA; Seneviratne C; Kane-Gerard S; Sathyasaikumar KV; Notarangelo FM; Schwarcz R; Kelly DL; Rowland LM; Buchanan RW
Neuropsychopharmacology; 2023 Oct; 48(11):1594-1601. PubMed ID: 37118058
[TBL] [Abstract][Full Text] [Related]
37. Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid.
Banerjee J; Alkondon M; Pereira EF; Albuquerque EX
J Pharmacol Exp Ther; 2012 May; 341(2):500-9. PubMed ID: 22344459
[TBL] [Abstract][Full Text] [Related]
38. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings.
Noyan H; Erdağ E; Tüzün E; Yaylım İ; Küçükhüseyin Ö; Hakan MT; Gülöksüz S; Rutten BPF; Saka MC; Atbaşoğlu C; Alptekin K; van Os J; Üçok A
Schizophr Res; 2021 Mar; 229():27-37. PubMed ID: 33609988
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.
Olsson SK; Samuelsson M; Saetre P; Lindström L; Jönsson EG; Nordin C; Engberg G; Erhardt S; Landén M
J Psychiatry Neurosci; 2010 May; 35(3):195-9. PubMed ID: 20420770
[TBL] [Abstract][Full Text] [Related]
40. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
